Pharmeuropa: Revised Chapter 2.9.3. Dissolution Test for Solid Dosage Forms published for comment
Recommendation
1/2 October 2024
Barcelona, Spain
Performance Evaluation and Monitoring for compliant Analytical Procedures and Processes
In the Pharmeuropa issue 35.1, a proposal for a revised chapter 2.9.3. Dissolution test for solid dosage forms was published. The deadline for submitting comments is 31 March 2023.
Compared to the monograph published in the 11th Edition of the Ph. Eur., the following changes are proposed:
- "The text has been edited to improve its clarity and to harmonise the terminology;
- the temperature requirement for the dissolution medium is now given with one digit after the decimal point to be consistent with the required accuracy requirement;
- the requirement for the pH value of the buffer solutions is now stated with two digits after the decimal point to be consistent with the required accuracy requirement;
- the section entitled Apparatus 3 (under Procedure) has been updated to indicate that the apparatus can be operated in two different ways (a) by conducting the test in one vessel or (b) by conducting the test using consecutive vessels."
The full text and further details on the revision and can be found, after registration, on the Pharmeuropa website.
Related GMP News
18.09.2024USP Draft Chapter on HPTLC Identification of Fixed Oils published for Comments
11.09.2024U.S. Manufacturer Faces FDA Warning Letter for Serious Quality Failures
05.09.2024Meet the AQCG Board Members at PharmaLab 2024
05.09.2024Q&As from the Live Online Training "Introduction to the AQCG's new AIQSV Guide" - Part 2
21.08.2024FDA issues Warning to Jordanian OTC Manufacturer
14.08.2024FDA Issues Warning Letter to Vietnamese Drug Manufacturer for CGMP Violations